In addition, ADAM17 is correlated with a high tumor grade and poor prognosis in patients with glioma and may be a potential diagnostic and therapeutic target, whereas ADAM10 is associated with glioma grade in glioma growth and development, particularly the invasiveness of the glioma. Here, ADAM10 is linked to central nervous system cancer.